| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.0019 | 1 |
| mRNA | NVP-BEZ235 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.0015 | 1 |
| mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | sirolimus:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |